Vitaeris was a Vancouver based biopharmaceutical company that has since been acquired by the Pennsylvania based CSL Behring. The company focused on the development and application of the previously discovered IL-6 antibody, that was developed to treat autoimmune conditions, towards the field of kidney transplant rejections as well as developing other treatments and therapies with the antibody,
| Loading Documents... |
